Kiora Pharmaceuticals Inc (KPHMW, KPRX)
CIK 1372514 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kiora Pharmaceuticals Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 8, 2026 | 8-K | 0001372514-26-000079 |
| Aug 19, 2026 | 8-K | 0001372514-26-000077 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001104659-26-097279 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001104659-26-097323 |
| Aug 10, 2026 | SCHEDULE 13G | 0001193125-26-341731 |
| Aug 7, 2026 | 10-Q | 0001372514-26-000074 |
| Aug 7, 2026 | 8-K | 0001372514-26-000075 |
| Jul 2, 2026 | 4 | 0001372514-26-000067 |
| Jul 2, 2026 | 4 | 0001372514-26-000065 |
| Jun 18, 2026 | 8-K | 0001372514-26-000063 |
| Jun 12, 2026 | 4 | 0001793796-26-000002 |
| Jun 12, 2026 | 4 | 0001855207-26-000002 |
| Jun 12, 2026 | 4 | 0001372514-26-000061 |
| Jun 12, 2026 | 4 | 0001895795-26-000001 |
| Jun 12, 2026 | 4 | 0001711576-26-000002 |
| Jun 12, 2026 | 4 | 0001861519-26-000002 |
| Jun 11, 2026 | 8-K | 0001372514-26-000059 |
| May 28, 2026 | 424B3 | 0001372514-26-000057 |
| May 22, 2026 | EFFECT | 9999999995-26-001753 |
| May 18, 2026 | S-3 | 0001372514-26-000050 |
| May 15, 2026 | SCHEDULE 13G | 0001172661-26-002365 |
| May 15, 2026 | SCHEDULE 13G/A | 0001104659-26-062696 |
| May 15, 2026 | SCHEDULE 13G/A | 0001104659-26-062628 |
| May 8, 2026 | 10-Q | 0001372514-26-000047 |
| May 8, 2026 | 8-K | 0001372514-26-000048 |